Effectiveness of an Ai-based Endoscopic Ultrasound Navigation System in the Training of Endoscopic Ultrasonics

Sponsor
Renmin Hospital of Wuhan University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05421520
Collaborator
(none)
8
1
2
18
0.4

Study Details

Study Description

Brief Summary

In the early stage, the investigators successfully constructed an artificial intelligence model-based ultrasonic endoscopy-assisted film reading system and named the modified system biliopancreatic Master. The system can realize real-time ultrasonic station recognition and anatomical mark recognition and provide doctors with corresponding operation techniques. This study aimed to verify the feasibility and effectiveness of the biliopancreatic master system developed by our project team in shortening the training period of ultrasound endoscopists through a single-center clinical study.

Condition or Disease Intervention/Treatment Phase
  • Device: Artificial intelligence assisted system
N/A

Detailed Description

Endoscopic ultrasonography is essential for diagnosing and treating biliary and pancreatic diseases. The total incidence of biliary and pancreatic diseases is as high as 121/100,000, causing about 14.3/100,000 deaths worldwide every year, posing a severe threat to the health and safety of all humanity. The biliopancreatic system is located deep in the abdominal cavity, which is relatively difficult to examine and lacks specific symptoms at the early stage of the disease. Hence, the prognosis is poor, and the five-year survival rate is low. Biliopancreatic ultrasound endoscopy can obtain the cross cross-section of the biliopancreatic system through ultrasonic detection, collect tissue samples for pathological biopsy through the puncture, and carry out operations such as flushing and drainage, radiofrequency ablation, abdominal ganglion block, and gastrojejunostomy. The device integrates detection and treatment. In terms of detection, endoscopic ultrasonography is close to the lesion tissue and can avoid influencing the abdominal cavity wall, gastrointestinal gas, and other organs. Compared with X-ray, CT, MRI, and different in vitro detection methods, endoscopic ultrasonography has technical advantages of high resolution, no ionizing radiation, and solid real-time performance. In terms of treatment, endoscopic ultrasound-guided puncture through natural lumen has the characteristics of minimally invasive, lower surgical risk and cost compared with surgical treatment, which can significantly improve the prognosis of patients with biliary and pancreatic diseases. Biliopancreatic endoscopic ultrasonography is essential for diagnosing and treating biliopancreatic system diseases.

The basis of endoscopic ultrasound diagnosis and treatment lies in the accurate identification and localization of lesions by ultrasound images. Ultrasound images are cross-section images of human tissues, mainly containing texture information that is difficult to be recognized by naked human eyes; for endoscopy, doctors lacking professional training and long-term practice, difficult to accurately identify the anatomical signs in the images, which significantly affects the accuracy of identification and localization of biliopancreatic lesions. Due to the low image recognition of ultrasonic endoscopy, the operation of ultrasonic endoscopy is difficult, and the training cycle is very long. Conventional European and American endoscopic ultrasound training programs lasted for three years, but in a clinical study, two-thirds of the physicians who participated in the standard training program failed to pass the ability assessment of endoscopic ultrasound. Although ultrasound endoscopy is one of the most sensitive methods for the diagnosis of pancreatic cancer, sensitivity (87.8%) is still significantly inadequate compared with optical endoscopy for the diagnosis of gastric cancer (96%) and colon cancer (97.1%). The existence of this problem means that the existing training in ultrasonic endoscopy needs to be optimized. In recent years, Artificial intelligence (AI) machine vision technology has developed rapidly and has been widely used in transportation, finance, medicine and other fields. Several studies have shown that the diagnostic ability of AI has surpassed that of human experts in some diseases, and some studies have confirmed the feasibility of the application of AI in endoscopic ultrasound image recognition. In a previous study, an artificial intelligence model was used to assist ultrasonic endoscopists in ultrasound film reading, which could significantly improve the accuracy of physicians in image positioning and anatomical marker segmentation. In the early stage, the investigators successfully constructed an artificial intelligence model-based ultrasonic endoscopy-assisted film reading system and named the modified system biliopancreatic Master. The system can realize real-time ultrasonic station recognition and anatomical mark recognition and provide doctors with corresponding operation techniques.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
8 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Experimental: novices with AI-assisted system control:without AI-assisted systemExperimental: novices with AI-assisted system control:without AI-assisted system
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Feasibility and Effectiveness of an Ai-based Endoscopic Ultrasound Navigation System in the Training of Endoscopic ultrasonics-a Prospective, Randomized, Single-center Clinical Trial
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: A novice with ai-assisted assistance

When patients are randomly assigned to the experimental group, the visiting physician will perform endoscopic ultrasound with the assistance of the ai-assisted system

Device: Artificial intelligence assisted system
A deep learning-based bile duct scanning system that can prompt endoscopists to scan standard stations, identify bile ducts and stones in real time

No Intervention: A novice without ai-assisted assistance

When the patients were randomly assigned to the control group, the visiting physician would not perform endoscopic ultrasonography with the assistance of the AI-assisted system

Outcome Measures

Primary Outcome Measures

  1. learning cycle for ultrasound endoscopists [No more than 1 year]

    The number of guided examinations required by the trainees to achieve the level of stable independent operation of ultrasonic endoscopy

Secondary Outcome Measures

  1. Duration of operation by ultrasound endoscopists [No more than 1 year]

    The time required to complete each operation, from the beginning to the end of the operation

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male or female aged 18 or above;

  • Endoscopic ultrasonography and related examinations are needed to further identify the characteristics of digestive tract diseases; .Able to read, understand and sign informed consent.

Exclusion Criteria:
  • Drug or alcohol abuse or mental disorder in the last 5 years;

  • Women who are pregnant or breastfeeding;

  • Anatomical changes caused by previous upper gastrointestinal surgery;

  • Patients with advanced tumors resulting in abnormal anatomical structure of upper digestive tract.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Renmin Hospital of Wuhan University Wuhan Hubei China 430060

Sponsors and Collaborators

  • Renmin Hospital of Wuhan University

Investigators

  • Principal Investigator: Yu Honggang, Doctor, Renmin Hospital of Wuhan University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Renmin Hospital of Wuhan University
ClinicalTrials.gov Identifier:
NCT05421520
Other Study ID Numbers:
  • EA-22-005
First Posted:
Jun 16, 2022
Last Update Posted:
Jun 24, 2022
Last Verified:
May 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Renmin Hospital of Wuhan University

Study Results

No Results Posted as of Jun 24, 2022